Our Products
Veterinary Vaccines
ABS Novacell Biopharmaceuticals develops veterinary vaccines that serve the needs of major livestock and companion animals, including cattle, horses, avians, fishes and household pets. These vaccines are produced using advanced biotechnological platforms such as mammalian, yeast, E. coli and insect cells, ensuring high standards of potency, safety and regulatory compliance. The company's focus on research innovation enables rapid response to emerging diseases like swine flu and bird flu, as well as the development of vaccines for seasonal threats and other critical pathogens.
Human Vaccines
ABS Novacell Biopharmaceuticals is pioneering the development of human vaccines that utilize animal stem cells as a platform for both production and innovation. These vaccines are designed to address serious infectious diseases by leveraging the unique biological properties of animal-derived stem cells, which enable scalable manufacturing, advanced antigen presentation and enhanced immune response. The company’s approach incorporates state-of-the-art R&D and proprietary cell line technologies, focusing on global health threats such as pandemic and seasonal flu, as well as emerging viruses.
Stem Cells
Stem cells are unique biological cells with the ability to self-renew and differentiate into various specialized cell types, making them essential for regenerative medicine and biotechnology applications. In vaccine development and therapeutics, animal stem cells serve as versatile platforms enabling large-scale production of vaccines and biologics with enhanced immune response properties. They provide a sustainable and scalable source for generating cells and proteins necessary for immunization, supporting more efficient and rapid vaccine development.
Diagnostic kits
Diagnostic kits are specialized medical tools designed to detect, diagnose and monitor diseases and health conditions by analyzing biological samples such as blood, urine, saliva, or swabs. These kits contain reagents and instructions to facilitate accurate testing, enabling healthcare providers to confirm disease presence, predict disease risk and guide treatment decisions. Diagnostic kits serve various purposes including identifying infectious agents, genetic abnormalities and biomarkers related to chronic diseases. The rise of at-home diagnostic kits has empowered individuals to conveniently perform health tests with rapid results, improving access to timely medical insights.
Generics
They provide a cost-effective alternative by making essential medications more accessible without compromising on quality, efficacy, or safety. Generic drugs undergo rigorous regulatory scrutiny to ensure they meet the same standards as branded medicines, including bioequivalence in absorption and action. Their availability promotes competition, reduces healthcare costs and increases treatment options for patients worldwide. Through generics, healthcare systems can allocate resources more efficiently, enabling wider access to vital therapies while maintaining high standards of patient care.
Sheep derived biodrugs (Surfactants) and Milk Proteins
Sheep-derived biodrugs, including surfactants and milk proteins, represent a specialized category of biologics developed from ovine sources. Surfactants derived from sheep enhance lung function by reducing surface tension, playing a critical role in treatments for respiratory distress and other pulmonary conditions. Milk proteins from sheep serve as high-value nutraceuticals with potential applications in immune support, anti-inflammatory therapies and tissue regeneration. ABS Novacell leverages proprietary extraction and purification technologies to produce these biodrugs with high purity and efficacy, supporting innovative and natural therapeutic solutions.
